Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bergeron

Showing results (31-40 of 461) with videos related to

Pageof 47
Sort By:
Biochimica Et Biophysica Acta|September 21, 1976
An enzymic analysis of a nuclear envelope fractionR Sikstrom, J Lanoix, J J Bergeron
Experimental Biology|January 1, 1985
Synthesis and release of plasminogen activator by lymphoid cell lines of malignant origin and its effect on lymphocyte cytotoxicityS K Sundar, J Bergeron, J Menezes
Health Care Financing Review|March 3, 1996
Why do so few HMOs offer Medicare risk plans in rural areas?C Serrato, R S Brown, J Bergeron
Tetrahedron|April 28, 2012
Synthesis of Heterobactins A and B and Nocardia HeterobactinRaymond J Bergeron, Shailendra Singh, Neelam Bharti
The Journal of Cell Biology|January 1, 1978
Passage of serum-destined proteins through the Golgi apparatus of rat liver. An examination of heavy and light Golgi fractionsJ J Bergeron, D Borts, J Cruz
Clinical and Experimental Immunology|June 1, 1984
Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicityS K Sundar, J Bergeron, J Menezes
Applied and Environmental Microbiology|May 1, 1990
Specificity of octopine uptake by Rhizobium and pseudomonas strainsJ Bergeron, R A Macleod, P Dion
Journal of Medicinal Chemistry|September 2, 1994
An investigation of desferrithiocin metabolismR J Bergeron, M Wollenweber, J Wiegand
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 24, 2001
Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trialA D Sniderman, J Bergeron, J Frohlich
Journal of Leukocyte Biology|April 23, 2005
ER-mediated phagocytosis: myth or reality?Etienne Gagnon, John J Bergeron, Michel Desjardins
Pageof 47

Showing results (31-40 of 461) with videos related to

Sort By:
Pageof 47
Biochimica Et Biophysica Acta|September 21, 1976
An enzymic analysis of a nuclear envelope fractionR Sikstrom, J Lanoix, J J Bergeron
Experimental Biology|January 1, 1985
Synthesis and release of plasminogen activator by lymphoid cell lines of malignant origin and its effect on lymphocyte cytotoxicityS K Sundar, J Bergeron, J Menezes
Health Care Financing Review|March 3, 1996
Why do so few HMOs offer Medicare risk plans in rural areas?C Serrato, R S Brown, J Bergeron
Tetrahedron|April 28, 2012
Synthesis of Heterobactins A and B and Nocardia HeterobactinRaymond J Bergeron, Shailendra Singh, Neelam Bharti
The Journal of Cell Biology|January 1, 1978
Passage of serum-destined proteins through the Golgi apparatus of rat liver. An examination of heavy and light Golgi fractionsJ J Bergeron, D Borts, J Cruz
Clinical and Experimental Immunology|June 1, 1984
Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicityS K Sundar, J Bergeron, J Menezes
Applied and Environmental Microbiology|May 1, 1990
Specificity of octopine uptake by Rhizobium and pseudomonas strainsJ Bergeron, R A Macleod, P Dion
Journal of Medicinal Chemistry|September 2, 1994
An investigation of desferrithiocin metabolismR J Bergeron, M Wollenweber, J Wiegand
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 24, 2001
Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trialA D Sniderman, J Bergeron, J Frohlich
Journal of Leukocyte Biology|April 23, 2005
ER-mediated phagocytosis: myth or reality?Etienne Gagnon, John J Bergeron, Michel Desjardins
Pageof 47